Navigation Links
Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations
Date:4/8/2009

AMSTERDAM, April 8 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma reported preliminary clinical data on ATIR(TM) showing its potential in mismatched bone marrow transplantations. Data was presented by the company's principal investigator Dr. Denis Claude Roy during the prestigious Presidential Symposium at the Annual European Bone Marrow Transplantation meeting (EBMT) in Goteborg, Sweden, on Monday, March 30, 2009. Only the 6 highest ranked presentations, representing the most promising new developments in the transplantation field, were selected for this Symposium.

ATIR(TM), a donor lymphocyte cell based preparation depleted of allo-reactive T-cells, is under development to prevent acute Graft versus Host Disease (GvHD) and allow for early immune reconstitution following a bone marrow transplantation with a fully mismatched (haplo-identical) donor.

Dr. Roy's presentation of clinical results from 19 end stage blood cancer patients with high risk leukemia and/or lymphoma using ATIR(TM) was very well received. These patients, each of whom did not have a matched donor available, were treated in a phase I/II dose escalating study with ATIR(TM) in a mismatched transplantation setting. No immune suppressants were used, which is in contrast to conventional transplant procedures. Nevertheless, no cases of severe grade III/IV acute GvHD occurred after ATIR(TM) infusion. Furthermore, the clinical data showed a reduction in the frequency of infectious episodes in the cohorts treated with the higher doses of ATIR(TM), as compared to the low dose cohorts. To date, patients in the higher dose cohorts show high survival rates (75%) with no transplant related mortality (TRM).

These results show that the selective depletion of allo-reactive T-cells in the ATIR(TM) cell based product by the proprietary photo-sensitizing agent TH9402 is highly effective and can result in fast and adequate immune reco
'/>"/>

SOURCE Kiadis Pharma
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
2. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
3. EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation
4. Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
5. Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc
6. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
7. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
8. Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft
9. New Pharmaxis Board Appointment
10. Pharmaxis Investor Conference Call
11. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 On April 19th the ... supermarkets to search for the growing antibiotic resistant bacteria ... from a year long study were released late last ... specifically meats, over previous years. For those suffering from ... of antibiotic resistant bacteria in food, may eventually help ...
(Date:5/23/2013)... , May 23, 2013 Pressure BioSciences, ... that the Company will host a teleconference to discuss ... a business update. The teleconference information is provided below: ... a.m. Eastern Daylight Time (EDT) Dial-in: (800) ... (302) 607-2001 (Int,l) Passcode: VS22823 For those ...
(Date:5/23/2013)... 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE (Europe) approved Total Artificial ... Scotland, which boasts more than 380,000 visitors annually, is ... powered by the Freedom® portable driver as part of ... advanced exhibitions of its kind. , “BodyWorks combines ...
(Date:5/23/2013)... St. Louis, Missouri (PRWEB) May 23, 2013 ... design and manufacture of complete thermal systems, recently ... more than 90 years of experience in designing ... most complete selection of products to serve diverse ... lead-time options is featured at the beginning of ...
Breaking Biology Technology:Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3Watlow Introduces Its New Industrial Heater Catalog 2
... 14 Response Genetics, Inc.,(Nasdaq: RGDX ), ... June 30, 2007. "The second quarter of ... our successful initial public offering in June," said,Kathleen ... are very,pleased by the recent developments that have ...
... Year, - 17 Percent Quarter-to-Quarter Revenue Gain Evidences Start of Turnaround ... for Core Business ... - DelSite Signs Additional Agreements, IRVING, Texas, Aug. 14 Carrington,Laboratories, Inc. (Nasdaq: ... compared to $6.5 million in the year ago,period. The revenue in the quarter just ...
... NEW YORK, Aug. 14 Summertime equals fun ... with irritable bowel syndrome (IBS), typical,summer fare could ... Koff, author of "Recipes for IBS," has more ... summer months to prevent IBS from,ruining their celebrations. ...
Cached Biology Technology:Response Genetics Reports Second Quarter 2007 Financial Results 2Response Genetics Reports Second Quarter 2007 Financial Results 3Response Genetics Reports Second Quarter 2007 Financial Results 4Response Genetics Reports Second Quarter 2007 Financial Results 5Response Genetics Reports Second Quarter 2007 Financial Results 6Response Genetics Reports Second Quarter 2007 Financial Results 7Response Genetics Reports Second Quarter 2007 Financial Results 8Carrington Reports Second Quarter 2007 Results 2Carrington Reports Second Quarter 2007 Results 3Carrington Reports Second Quarter 2007 Results 4Carrington Reports Second Quarter 2007 Results 5Carrington Reports Second Quarter 2007 Results 6Carrington Reports Second Quarter 2007 Results 7
(Date:5/22/2013)... join together in a major new effort to educate ... providing Earth,s people with clean water that looms ahead ... comment article in the current edition of Chemical ... American Chemical Society (ACS), the world,s largest scientific society. ... and Jerald L. Schnoor, Ph.D., explain that shortages of ...
(Date:5/22/2013)... is responsible for legionellosis, an infectious disease that can ... pathogen has developed a complex method enabling it to ... avoiding these acting against the infectious bacteria. , Research ... in which teams from the National Institute of Health ... in Barcelona (BSC) have also participated, has described for ...
(Date:5/21/2013)... Biologists have known for a long time that some ... well understood, particularly for plants. But it may be ... Australian National University and the U. S. National Evolutionary ... published 21 May in the journal Nature Communications ... faster-changing genomes. , Drawing from a database of global ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Small but speedy: Short plants live in the evolutionary fast lane 2
... Accurate duplication of genetic material and the faithful ... initiation of DNA replication is linked both to cell ... other "eukaryotes," the assembly of a multi-protein complex called ... initiation of DNA replication. As the name implies, origin ...
... ,PROVIDENCE, R.I. [Brown University] Seemingly healthy adults, if ... physiological consequences decades later. In research published online last ... led by psychiatrists at Brown University and Butler Hospital ... kids appear to have an elevated inflammatory response to ...
... Mont. -- Invasive plants make life tougher for farmers and ... Missouri River Basin, so why not turn the plants into ... Russian olive and saltcedar alone could supply biomass far into ... Converting invasive plants to fuel is an intriguing idea ...
Cached Biology News:Novel protein critical for cellular proliferation discovered 2Childhood adversity may lead to unhealthy stress response in adult life 2Childhood adversity may lead to unhealthy stress response in adult life 3Montana State, partners in 6 states consider converting invasive plants to fuel 2Montana State, partners in 6 states consider converting invasive plants to fuel 3Montana State, partners in 6 states consider converting invasive plants to fuel 4
... CellBIND surface is produced by a patented ... surface giving more consistent, even cell attachment, ... cell attachment and growth uunder difficult conditions, ... CellBIND may provide a more ecominic alternative ...
Mouse polyclonal antibody raised against a partial recombinant RDH5. NCBI Entrez Gene ID = 5959...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The version upgrade allows upgrade of an established version of...
Mouse monoclonal antibody raised against a partial recombinant MYO7A. NCBI Entrez Gene ID = MYO7A...
Biology Products: